Unicycive Therapeutics, Inc. (UNCY) Misses Q2 EPS by 9c

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) reported Q2 EPS of ($0.29), $0.09 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Unicycive Therapeutics, Inc. (UNCY) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Active options: TSLA NVDA AMZN GOOGL AAPL SPCX MSFT NFLX INTC
• Proshares Ultra SpaceX (SPCF) call put ratio 1.7 calls to 1 put with a focus on January 42 calls as share price down 21%